Neupogen and Panic attack - a phase IV clinical study of FDA data

Summary:

Panic attack is reported as a side effect among people who take Neupogen (filgrastim), especially for people who are male, 50-59 old, also take Simvastatin, and have Nausea.

The phase IV clinical study analyzes which people have Panic attack when taking Neupogen. It is created by eHealthMe based on reports of 23,793 people who have side effects when taking Neupogen from the FDA, and is updated regularly.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.

What is Panic attack?

Panic attack is found to be associated with 2,191 drugs and 2,082 conditions by eHealthMe. Check the latest studies of Panic attack.

On Jun, 27, 2026

23,793 people reported to have side effects when taking Neupogen.
Among them, 21 people (0.09%) have Panic attack.

Among these 21 people:

What is the gender of people who have Panic attack when taking Neupogen? *

female: 45 %
male: 55 %

What is the age of people who have Panic attack when taking Neupogen? *

What are other drugs people take besides Neupogen? *

What are other side effects people have besides Panic attack? *

Stress And Anxiety: 13 people, 61.90%
Dyspnea (difficult or laboured breathing): 12 people, 57.14%
Diarrhea: 12 people, 57.14%
Pain: 12 people, 57.14%
Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 11 people, 52.38%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 11 people, 52.38%
Osteonecrosis Of Jaw (death of bone of jaw): 11 people, 52.38%
High Blood Pressure: 11 people, 52.38%
General Physical Health Deterioration (weak health status): 11 people, 52.38%
Nausea And Vomiting: 11 people, 52.38%

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 9 people, 42.86%
T-Cell Lymphoma (a blood cell cancer): 2 people, 9.52%
Hepatitis C: 2 people, 9.52%
Pulmonary Aspergilloma (Mycetoma) (mass caused by a fungal infection that usually grows in lung): 1 person, 4.76%
Pleural Disorder: 1 person, 4.76%
Multiple Myeloma (cancer of the plasma cells): 1 person, 4.76%
Liver Disorder (liver diseases): 1 person, 4.76%
Fungal Infection: 1 person, 4.76%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 1 person, 4.76%
Breast Cancer: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Neupogen and have Panic attack?

- Check whether Panic attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Neupogen:

Neupogen (23,898 reports)

Panic attack treatments and more:

Panic attack (65,704 reports)

Browse all side effects of Neupogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Panic attack:

Panic attack (2,191 drugs)

Browse all the conditions that are associated with Panic attack:

Panic attack (2,082 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on filgrastim (the active ingredients of Neupogen) and Neupogen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.